AACR Immuno-Oncology (AACR IO)
Organized by American Association for Cancer Research
The AACR Immuno-Oncology (AACR IO) conference is the third in a series, focusing on basic, translational, and clinical research in immunology, inflammation, and immunothe...
- Dates
- Feb 28 - Mar 3, 2027
- Location
- Los Angeles, CA
- Deadline
- -
- Attendees
- 2,000
- Vendors
- Unlock to view
About this conference
The AACR Immuno-Oncology (AACR IO) conference is the third in a series, focusing on basic, translational, and clinical research in immunology, inflammation, and immunotherapies for cancer. This includes immuno-oncology (IO) drugs, inflammatory modulators, vaccines, and cellular therapies. The program features keynote lectures, major symposia, spotlight sessions, educational sessions, and poster sessions with exhibits, covering the entire spectrum of the IO field. Key highlights include late-breaking clinical trials sessions that will showcase new agents, novel IO combinations, and practice-changing clinical trial results. The conference provides a crucial opportunity for networking with leading immuno-oncology thought-leaders from around the world.
Sponsorship options
Various sponsorship opportunities are available, including Lead Supporter ($50,000), Supporter ($25,000), Poster Sessions ($15,000), Scholar-in-Training Awards ($5,000), Seating ($15,000), Hotel Key Cards ($25,000), Mobile Charging Lounges ($25,000), Reusable Bottle for Water Stations ($25,000), and Coffee Breaks ($5,000 per break). Contact Corporate Alliances for further details.
Attendee roles and functions
Roles and teams represented at AACR Immuno-Oncology (AACR IO)
Conference verticals
Public-sector and commercial markets covered by this event
Vendors at this conference
Unlock full vendor list
See sponsors, exhibitors, and vendors attending this conference.